San Francisco, California, Jul 19, 2018: A new research study by TMR Research presents an exhaustive assessment of the global market for opioid withdrawal treatment. The research report, titled “Opioid Withdrawal Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2028,” assesses the prominent trends, driving forces, restraints, market potentials, opportunities, and the challenges to find out the future prospects and performance of this market.
Get Sample Copy of this Report @
According to the research study, the significant rise in the research and development activities and the advancement in technologies are boosting the growth of this market, remarkably. The augmenting demand of outpatient rehabilitation treatment centers are expected to support the growth of this market in the years to come, reports the market study.
On the basis of the geography, Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America can be considered as the key regional markets for opioid withdrawal treatment across the world. Among these, North America has been dominating the global market due to high prevalence of chronic diseases and the rising usage of opioid drugs, such as pain killers, among people. This regional market is likely to remain on the top over the next few years. The market in Asia Pacific is also projected to witness a significant rise in the years to come, states the research report.
Read Comprehensive Overview of Report @
The vendor landscape of the global market for opioid withdrawal treatments has also been evaluated in this research report to gain an insight into the existing hierarchy among the leading participants. The market demonstrates a highly fragmented business landscape. Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis, Johnson & Johnson Services, Sanofi N.V, F. Hoffmann-La Roche Ltd., and Bayer AG are some of the key players in this market, reviewed in this research study.